Ilmarinen Mutual Pension Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Ilmarinen Mutual Pension Insurance’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.42M	Hold	11,900	–	–	0.05%	206
2026 Q1	$9.19M	Sell	11,900 -3,000	-20%	-$2.3M	0.07%	167
2025 Q4	$11.5M	Hold	14,900	–	–	0.09%	123
2025 Q3	$8.38M	Hold	14,900	–	–	0.06%	149
2025 Q2	$7.82M	Hold	14,900	–	–	0.06%	147
2025 Q1	$9.45M	Buy	14,900 +3,500	+31%	+$2.41M	0.08%	122
2024 Q4	$8.12M	Buy	11,400 +3,400	+43%	+$2.85M	0.07%	150
2024 Q3	$8.41M	Hold	8,000	–	–	0.09%	113
2024 Q2	$8.41M	Hold	8,000	–	–	0.1%	105
2024 Q1	$7.7M	Hold	8,000	–	–	0.09%	116
2023 Q4	$7.03M	Hold	8,000	–	–	0.1%	131
2023 Q3	$6.58M	Hold	8,000	–	–	0.09%	128
2023 Q2	$5.75M	Buy	8,000 +3,000	+60%	+$2.31M	0.07%	152
2023 Q1	$4.11M	Buy	+5,000	New	+$3.77M	0.06%	184

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ilmarinen Mutual Pension Insurance's REGN Position: Q2 2026 in Review

Ilmarinen Mutual Pension Insurance held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 11,900 shares worth $7.42M. The position accounts for 0.05% of the portfolio, ranked #206.

Ilmarinen Mutual Pension Insurance first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.5M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Ilmarinen Mutual Pension Insurance held 11,900 shares of Regeneron Pharmaceuticals worth $7.42M as of Q2 2026.
Ilmarinen Mutual Pension Insurance left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.05% of Ilmarinen Mutual Pension Insurance's portfolio in Q2 2026, its #206 holding.
Ilmarinen Mutual Pension Insurance first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Ilmarinen Mutual Pension Insurance's Regeneron Pharmaceuticals position peaked at $11.5M in Q4 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Ilmarinen Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.